Impact Therapeutics CEO Cai lifts stake to 6.56% after buying 100,000 shares at HK$14.61 each

PUBT · 3d ago
Impact Therapeutics CEO Cai lifts stake to 6.56% after buying 100,000 shares at HK$14.61 each
  • CEO Sui Xiong Cai bought 100,000 ordinary shares in the open market, lifting his stake to 6.56%.
  • Purchase price averaged HK$ 14.61 per share; holding rose to 18,540,884 shares.
  • Transaction represented about 0.04% of issued shares; disclosure dated Sept. 3, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Therapeutics Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260903-12317238), on September 03, 2026, and is solely responsible for the information contained therein.